Biology and prognostic factors of breast cancer.
Davidson
N E
NE
Johns Hopkins Oncology Center, Baltimore, Maryland.
D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000235:genetics* / Q000503:physiopathology; D002402:Cathepsin D / Q000502:physiology; D002455:Cell Division; D016147:Genes, Tumor Suppressor; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D009362:Neoplasm Metastasis; D011003:Ploidies; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology
D014408:Biomarkers, Tumor; D002402:Cathepsin D; D006133:Growth Substances; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D013629:Tamoxifen